SILMEN-5

This brand name is authorized in Nigeria.

Active ingredients

The drug SILMEN-5 contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Meningococcal group A Polysaccharide (conjugated to TT) UNII `1I86B47NY4` - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN
	Read more about Meningococcal serogroup A polysaccharide vaccine
`2`	Meningococcal group C Polysaccharide (conjugated to CRM197) UNII `9B7N7Y96MK` - NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CRM-197 ADIPIC ACID CONJUGATE
	Read more about Meningococcal serogroup C polysaccharide vaccine
`3`	Meningococcal group Y Polysaccharide (conjugated to CRM197) UNII `CBZ4BH7TJ1` - NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN
	Read more about Meningococcal serogroup Y polysaccharide vaccine
`4`	Meningococcal group W Polysaccharide (conjugated to CRM197) UNII `9F8QQ6EER1` - NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN
	Read more about Meningococcal serogroup W135 polysaccharide vaccine
`5`	Meningococcal group X Polysaccharide (conjugated to TT)
	Read more about Meningococcal serogroup X polysaccharide

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A6-100157
Switch country to Nigeria in order to find specific presentations of SILMEN-5

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.